Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.53B |
| 2 |
American Express
AXP
|
+$368M |
| 3 |
Capital One
COF
|
+$138M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$98.1M |
| 5 |
Apollo Global Management
APO
|
+$96.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.04B |
| 2 |
Microsoft
MSFT
|
+$804M |
| 3 |
Amazon
AMZN
|
+$353M |
| 4 |
NVIDIA
NVDA
|
+$280M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.21% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.24% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVMI
1101
Nova
NVMI
$13.3B
| $7.07M | ﹤0.01% |
62,593
| – | – |
|
1102
Ultragenyx Pharmaceutical
RARE
$2.61B
| $7.05M | ﹤0.01% |
152,852
+9,100
| +6% | +$422K |
|
1103
Glaukos
GKOS
$10.9B
| $7.05M | ﹤0.01% |
99,000
-4,000
| -4% | -$230K |
|
1104
Intellia Therapeutics
NTLA
$1.67B
| $7.03M | ﹤0.01% |
172,500
+19,700
| +13% | +$799K |
|
1105
Denali Therapeutics
DNLI
$3.9B
| $7.03M | ﹤0.01% |
238,100
+32,900
| +16% | +$925K |
|
1106
Azenta
AZTA
$1.46B
| $7.02M | ﹤0.01% |
150,400
-11,500
| -7% | -$504K |
|
1107
American States Water
AWR
$3.53B
| $7M | ﹤0.01% |
80,500
+700
| +0.9% | +$62.7K |
|
1108
Brighthouse Financial
BHF
$3.37B
| $6.98M | ﹤0.01% |
147,400
-1,800
| -1% | -$77.5K |
|
1109
Grand Canyon Education
LOPE
$3.76B
| $6.98M | ﹤0.01% |
67,600
+400
| +0.6% | +$44K |
|
1110
Coca-Cola Consolidated
COKE
$12.6B
| $6.97M | ﹤0.01% |
109,650
+1,000
| +0.9% | +$61.9K |
|
1111
AppFolio
APPF
$7.23B
| $6.97M | ﹤0.01% |
40,500
-1,300
| -3% | -$189K |
|
1112
Spectrum Brands
SPB
$2.07B
| $6.97M | ﹤0.01% |
89,299
+1,300
| +1% | +$92.8K |
|
1113
TAL Education Group
TAL
$6.46B
| $6.97M | ﹤0.01% |
1,169,165
-8,600
| -0.7% | -$51.5K |
|
1114
LCI Industries
LCII
$2.58B
| $6.96M | ﹤0.01% |
55,100
+200
| +0.4% | +$22.9K |
|
|
NVEI
1115
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $6.96M | ﹤0.01% |
235,400
-26,600
| -10% | -$938K |
|
1116
Lyft
LYFT
$6.62B
| $6.94M | ﹤0.01% |
724,000
+39,600
| +6% | +$381K |
|
1117
iRhythm Holdings
IRTC
$4.17B
| $6.93M | ﹤0.01% |
66,400
+1,400
| +2% | +$168K |
|
|
ERF
1118
DELISTED
Enerplus Corporation
ERF
| $6.92M | ﹤0.01% |
476,855
-12,200
| -2% | -$178K |
|
1119
Freshpet
FRPT
$3.5B
| $6.88M | ﹤0.01% |
104,550
+900
| +0.9% | +$58.9K |
|
1120
FTAI Aviation
FTAI
$22.3B
| $6.88M | ﹤0.01% |
217,192
+2,100
| +1% | +$59.5K |
|
1121
Pacific Biosciences
PACB
$357M
| $6.87M | ﹤0.01% |
516,646
+53,000
| +11% | +$644K |
|
1122
Brink's
BCO
$4.71B
| $6.87M | ﹤0.01% |
101,300
+1,000
| +1% | +$66.9K |
|
1123
Progyny
PGNY
$2.02B
| $6.86M | ﹤0.01% |
174,500
+14,200
| +9% | +$513K |
|
1124
Assured Guaranty
AGO
$3.38B
| $6.86M | ﹤0.01% |
123,000
| – | – |
|
1125
Ambarella
AMBA
$3.6B
| $6.86M | ﹤0.01% |
81,933
+3,100
| +4% | +$227K |
|
Similar funds
Swiss National Bank's Q2 2023 Portfolio in Review
As of Q2 2023, Swiss National Bank held 2,706 positions worth $147B, up 0.92% from $146B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank withdrew a net $9.97B in Q2 2023, closing 106 positions and reducing 972 holdings. Its most notable exit was Shaw Communications Inc., an estimated $57.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Berkshire Hathaway Class B worth $1.6B.
- Swiss National Bank's largest Q2 2023 buy was Berkshire Hathaway Class B: 4,684,505 shares worth $1.6B.
- Swiss National Bank added most to Uber in Q2 2023, an estimated $22.7M increase.
- Swiss National Bank's biggest Q2 2023 reduction was Apple, cutting an estimated $1.04B.
- Swiss National Bank fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $57.3M.
- Swiss National Bank's ten largest holdings make up 28% of its $147B portfolio in Q2 2023.
- Swiss National Bank opened 63 new positions and closed 106 in Q2 2023.
- Swiss National Bank's portfolio value rose 0.92% quarter-over-quarter to $147B.
Based on Swiss National Bank's 13F filing for Q2 2023, filed 9 Aug 2023.